Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.

about

Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus

P2860

Q34508850-0A351E1B-3B64-464E-848E-68C21035D0C4

P2860

Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.

Item

http://www.wikidata.org/entity/Q36410392

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Clinicopathological characteri ...... tive Barrett's adenocarcinoma.

@ast

Clinicopathological characteri ...... tive Barrett's adenocarcinoma.

@en

type

Item

label

Clinicopathological characteri ...... tive Barrett's adenocarcinoma.

@ast

Clinicopathological characteri ...... tive Barrett's adenocarcinoma.

@en

prefLabel

Clinicopathological characteri ...... tive Barrett's adenocarcinoma.

@ast

Clinicopathological characteri ...... tive Barrett's adenocarcinoma.

@en

P1476

Clinicopathological characteri ...... itive Barrett's adenocarcinoma

@en

P2093

Hiroyuki Okada

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Yanai

http://www.w3.org/2001/XMLSchema#string

Katsuyohi Takata

http://www.w3.org/2001/XMLSchema#string

Koichi Ichimura

http://www.w3.org/2001/XMLSchema#string

Seiji Kawano

http://www.w3.org/2001/XMLSchema#string

Shunsuke Tanabe

http://www.w3.org/2001/XMLSchema#string

Tadashi Yoshino

http://www.w3.org/2001/XMLSchema#string

Takehiro Tanaka

http://www.w3.org/2001/XMLSchema#string

Yasuharu Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

HER2 testing in gastric cancer: a practical approach

Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.

Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.

Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia.

Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.

Review article: Barrett's oesophagus and carcinoma in Japan.

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study.

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.

P304

6263-6268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I43.6263

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Atsushi Fujimura

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233770885

http://www.w3.org/2001/XMLSchema#string

P698

23180947

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

3501775

http://www.w3.org/2001/XMLSchema#string

Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.

about

P2860

P2860

Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932